Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113800356 | 11380035 | 6 | F | 20051005 | 20160706 | 20150814 | 20160715 | EXP | PHHY2013CA086553 | SANDOZ | 62.28 | YR | F | Y | 0.00000 | 20160715 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113800356 | 11380035 | 1 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, EVERY 6 WEEKS | U | 0 | 20 | MG | |||||||
| 113800356 | 11380035 | 2 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, EVERY 8 WEEKS | U | 0 | 20 | MG | |||||||
| 113800356 | 11380035 | 3 | PS | METOPROLOL. | METOPROLOL | 1 | Unknown | 75 MG, BID | Y | 73288 | 75 | MG | BID | ||||||
| 113800356 | 11380035 | 4 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | UNK | U | 0 | |||||||||
| 113800356 | 11380035 | 5 | C | POTASSIUM | POTASSIUM | 1 | Unknown | UNK | U | 0 | |||||||||
| 113800356 | 11380035 | 6 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Unknown | 7.5 MG, UNK | U | 0 | 7.5 | MG | |||||||
| 113800356 | 11380035 | 7 | C | MONOPRIL | FOSINOPRIL SODIUM | 1 | Unknown | UNK | U | 0 | |||||||||
| 113800356 | 11380035 | 8 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 113800356 | 11380035 | 9 | C | A S A | 2 | Unknown | UNK | U | 0 | COATED TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 113800356 | 11380035 | 1 | Insulinoma |
| 113800356 | 11380035 | 3 | Atrial fibrillation |
| 113800356 | 11380035 | 4 | Product used for unknown indication |
| 113800356 | 11380035 | 5 | Product used for unknown indication |
| 113800356 | 11380035 | 6 | Product used for unknown indication |
| 113800356 | 11380035 | 7 | Product used for unknown indication |
| 113800356 | 11380035 | 8 | Product used for unknown indication |
| 113800356 | 11380035 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 113800356 | 11380035 | OT |
| 113800356 | 11380035 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 113800356 | 11380035 | Atrial fibrillation | |
| 113800356 | 11380035 | Blindness | |
| 113800356 | 11380035 | Blood glucose increased | |
| 113800356 | 11380035 | Blood pressure increased | |
| 113800356 | 11380035 | Blood pressure systolic increased | |
| 113800356 | 11380035 | Body temperature decreased | |
| 113800356 | 11380035 | Dehydration | |
| 113800356 | 11380035 | Dyspnoea | |
| 113800356 | 11380035 | Feeling abnormal | |
| 113800356 | 11380035 | Heart rate decreased | |
| 113800356 | 11380035 | Heart rate irregular | |
| 113800356 | 11380035 | Inappropriate schedule of drug administration | |
| 113800356 | 11380035 | Osteoarthritis | |
| 113800356 | 11380035 | Peripheral swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 113800356 | 11380035 | 1 | 20051005 | 0 | ||
| 113800356 | 11380035 | 3 | 201512 | 0 |